AI assistant
IONIS PHARMACEUTICALS INC — Director's Dealing 2019
Jan 17, 2019
30591_dirs_2019-01-17_0a2a65c0-125b-45f8-ae6d-2ac767f607bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-01-15
Reporting Person: O'NEIL PATRICK R. (SVP Legal & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-15 | Common Stock | M | 7823 | — | Acquired | 22341 | Direct |
| 2019-01-15 | Common Stock | F | 2734 | $58.26 | Disposed | 19607 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-15 | Restricted Stock Units | $ | A | 22131 | Acquired | Common Stock (22131) | Direct | |
| 2019-01-15 | Restricted Stock Units | $ | M | 7823 | Disposed | Common Stock (7823) | Direct |
Footnotes
F1: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
F2: Shares withheld to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
F3: Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan.
F4: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F5: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.